BioVersys AG is a privately held Swiss pharmaceutical company focusing on R&D of small molecules acting on novel bacterial targets with applications in Anti-Microbial Resistance (AMR) and targeted microbiome modulation.

Cooperation possibilities

Partnering options for the co-development of TRIC molecules restoring the activity of approved antibiotics against severe hospital acquired bacterial infections. TRIC molecules have the ability to switch-off bacterial resistance.

Location

Hochbergerstrasse 60c, 4057 Basel, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2010

  • Number of employees in Switzerland

    10-19

Key business